Autophagy-Related Genes in Atherosclerosis

Yuankun Chen1,2, Ao Zeng1, Shumiao He1,3

  • 1School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.

Insights

Autophagy-related genes (ARGs) are crucial in atherosclerosis (AS). This study analyzed differentially expressed ARGs, revealing their role in AS pathophysiology and potential for treating cardiovascular diseases (CVDs).

Area of Science:

  • Biomedical research
  • Molecular biology
  • Genetics

Background:

  • Atherosclerosis (AS) is a chronic inflammatory vascular disease and a primary cause of cardiovascular/cerebrovascular diseases (CVDs).
  • Autophagy-related genes (ARGs) are integral to AS pathophysiological processes.
  • The expression profiles of ARGs have been underexplored in the context of autophagy and AS.

Purpose of the Study:

  • To investigate the relationship between autophagy and AS by analyzing the expression profile of ARGs.
  • To identify potential therapeutic targets for CVDs by understanding the role of ARGs in AS.

Main Methods:

  • Utilized the GSE57691 dataset containing aortic atheroma and normal aortic tissues.
  • Analyzed differentially expressed ARGs using protein-protein interaction (PPI), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses.
  • Explored related microRNAs (miRNAs) and transcription factors through network analysis.

Main Results:

  • Identified 41 differentially expressed ARGs in the GSE57691 dataset.
  • GO and KEGG analyses indicated enrichment in autophagy, autophagosome, and related signaling pathways.
  • Highlighted key ARGs (ATG5, MAP1LC3B, MAPK3, MAPK8, RB1CC1) and identified 11 miRNAs and 6 transcription factors involved in regulatory networks.

Conclusions:

  • Autophagy and ARGs significantly influence the pathophysiology of AS.
  • Findings provide new insights into the molecular mechanisms of AS and potential therapeutic strategies for CVDs.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
260
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
Inflammation01:38

Inflammation

Overview
56.6K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
80
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
542